LINC02079

Across TCGA pan-cancer cohorts, LINC02079 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LINC02079 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC02079 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02079 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LGG, and BLCA are the cancer types where LINC02079 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.616	.004	14	view →
LGG	DFS	Median	All	0.216	0.728	.022	3	view →
BLCA	DFS	Median	III,IV	0.163	0.572	.041	3	view →
SKCM	DFS	Median	III,IV	0.087	0.647	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LINC02079–UCEC (DFS)

Open the UCEC breakdown →